Annual FCF
-$24.94 M
-$4.15 M-19.94%
December 31, 2023
Summary
- As of February 26, 2025, SLNO annual free cash flow is -$24.94 million, with the most recent change of -$4.15 million (-19.94%) on December 31, 2023.
- During the last 3 years, SLNO annual FCF has risen by +$291.00 thousand (+1.15%).
- SLNO annual FCF is now -2713.31% below its all-time high of -$886.50 thousand, reached on December 31, 2013.
Performance
SLNO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$15.12 M
+$2.54 M+14.39%
September 30, 2024
Summary
- As of February 26, 2025, SLNO quarterly free cash flow is -$15.12 million, with the most recent change of +$2.54 million (+14.39%) on September 30, 2024.
- Over the past year, SLNO quarterly FCF has stayed the same.
- SLNO quarterly FCF is now -825.52% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$51.63 M
-$8.79 M-20.50%
September 30, 2024
Summary
- As of February 26, 2025, SLNO TTM free cash flow is -$51.63 million, with the most recent change of -$8.79 million (-20.50%) on September 30, 2024.
- Over the past year, SLNO TTM FCF has stayed the same.
- SLNO TTM FCF is now -2577.87% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SLNO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | 0.0% | 0.0% |
| 3 y3 years | +1.1% | 0.0% | 0.0% |
| 5 y5 years | -113.3% | 0.0% | 0.0% |
SLNO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | +10.3% | -226.7% | +14.4% | -148.3% | at low |
| 5 y | 5-year | -43.4% | +10.3% | -226.7% | +14.4% | -196.8% | at low |
| alltime | all time | -2713.3% | +10.3% | -825.5% | +14.4% | -2577.9% | at low |
Soleno Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.12 M(-14.4%) | -$51.63 M(+20.5%) |
| Jun 2024 | - | -$17.66 M(+40.8%) | -$42.84 M(+39.3%) |
| Mar 2024 | - | -$12.54 M(+98.6%) | -$30.75 M(+23.3%) |
| Dec 2023 | -$24.94 M(+19.9%) | -$6.31 M(-0.3%) | -$24.94 M(+4.9%) |
| Sep 2023 | - | -$6.33 M(+13.8%) | -$23.77 M(+7.6%) |
| Jun 2023 | - | -$5.57 M(-17.3%) | -$22.10 M(+4.4%) |
| Mar 2023 | - | -$6.73 M(+30.7%) | -$21.16 M(+1.8%) |
| Dec 2022 | -$20.79 M(-25.2%) | -$5.15 M(+10.6%) | -$20.79 M(-7.7%) |
| Sep 2022 | - | -$4.66 M(+0.6%) | -$22.52 M(-3.2%) |
| Jun 2022 | - | -$4.63 M(-27.3%) | -$23.28 M(-12.7%) |
| Mar 2022 | - | -$6.36 M(-7.5%) | -$26.66 M(-4.1%) |
| Dec 2021 | -$27.79 M(+10.2%) | -$6.88 M(+27.1%) | -$27.79 M(+0.0%) |
| Sep 2021 | - | -$5.41 M(-32.5%) | -$27.79 M(-2.6%) |
| Jun 2021 | - | -$8.01 M(+7.0%) | -$28.54 M(+5.5%) |
| Mar 2021 | - | -$7.49 M(+9.0%) | -$27.06 M(+7.3%) |
| Dec 2020 | -$25.23 M(+45.0%) | -$6.87 M(+11.4%) | -$25.23 M(+7.6%) |
| Sep 2020 | - | -$6.17 M(-5.6%) | -$23.44 M(+6.6%) |
| Jun 2020 | - | -$6.53 M(+15.5%) | -$21.99 M(+13.6%) |
| Mar 2020 | - | -$5.66 M(+11.4%) | -$19.36 M(+11.3%) |
| Dec 2019 | -$17.40 M(+48.8%) | -$5.08 M(+7.7%) | -$17.40 M(+8.4%) |
| Sep 2019 | - | -$4.72 M(+21.0%) | -$16.05 M(+14.5%) |
| Jun 2019 | - | -$3.90 M(+5.5%) | -$14.02 M(+8.9%) |
| Mar 2019 | - | -$3.70 M(-1.1%) | -$12.87 M(+10.1%) |
| Dec 2018 | -$11.69 M | -$3.74 M(+39.4%) | -$11.69 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$2.68 M(-2.5%) | -$10.68 M(+6.4%) |
| Jun 2018 | - | -$2.75 M(+9.2%) | -$10.04 M(-2.4%) |
| Mar 2018 | - | -$2.52 M(-7.7%) | -$10.29 M(+3.4%) |
| Dec 2017 | -$9.95 M(-26.4%) | -$2.73 M(+33.6%) | -$9.95 M(+0.5%) |
| Sep 2017 | - | -$2.04 M(-31.8%) | -$9.90 M(-7.0%) |
| Jun 2017 | - | -$3.00 M(+37.2%) | -$10.65 M(-8.9%) |
| Mar 2017 | - | -$2.18 M(-18.6%) | -$11.69 M(-13.5%) |
| Dec 2016 | -$13.51 M(+27.4%) | -$2.68 M(-3.8%) | -$13.51 M(-5.6%) |
| Sep 2016 | - | -$2.79 M(-31.0%) | -$14.32 M(-1.7%) |
| Jun 2016 | - | -$4.04 M(+0.9%) | -$14.57 M(+13.9%) |
| Mar 2016 | - | -$4.00 M(+14.8%) | -$12.80 M(+20.7%) |
| Dec 2015 | -$10.61 M(+134.9%) | -$3.49 M(+14.6%) | -$10.61 M(+21.8%) |
| Sep 2015 | - | -$3.04 M(+34.3%) | -$8.71 M(+25.8%) |
| Jun 2015 | - | -$2.27 M(+25.2%) | -$6.92 M(+19.0%) |
| Mar 2015 | - | -$1.81 M(+14.1%) | -$5.82 M(+28.8%) |
| Dec 2014 | -$4.51 M(+409.3%) | -$1.59 M(+26.2%) | -$4.51 M(+23.7%) |
| Sep 2014 | - | -$1.26 M(+8.4%) | -$3.65 M(+10.0%) |
| Jun 2014 | - | -$1.16 M(+128.1%) | -$3.32 M(-4.6%) |
| Mar 2014 | - | -$509.00 K(-29.6%) | -$3.48 M(+292.5%) |
| Dec 2013 | -$886.50 K(-74.7%) | -$722.50 K(-21.9%) | -$886.50 K(+440.5%) |
| Sep 2013 | - | -$925.10 K(-30.0%) | -$164.00 K(-121.5%) |
| Jun 2013 | - | -$1.32 M(-163.5%) | $761.10 K(-63.5%) |
| Mar 2013 | - | $2.08 M | $2.08 M |
| Dec 2012 | -$3.50 M | - | - |
FAQ
- What is Soleno Therapeutics annual free cash flow?
- What is the all time high annual FCF for Soleno Therapeutics?
- What is Soleno Therapeutics annual FCF year-on-year change?
- What is Soleno Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly FCF year-on-year change?
- What is Soleno Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Soleno Therapeutics?
- What is Soleno Therapeutics TTM FCF year-on-year change?
What is Soleno Therapeutics annual free cash flow?
The current annual FCF of SLNO is -$24.94 M
What is the all time high annual FCF for Soleno Therapeutics?
Soleno Therapeutics all-time high annual free cash flow is -$886.50 K
What is Soleno Therapeutics annual FCF year-on-year change?
Over the past year, SLNO annual free cash flow has changed by -$4.15 M (-19.94%)
What is Soleno Therapeutics quarterly free cash flow?
The current quarterly FCF of SLNO is -$15.12 M
What is the all time high quarterly FCF for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly free cash flow is $2.08 M
What is Soleno Therapeutics quarterly FCF year-on-year change?
Over the past year, SLNO quarterly free cash flow has changed by $0.00 (0.00%)
What is Soleno Therapeutics TTM free cash flow?
The current TTM FCF of SLNO is -$51.63 M
What is the all time high TTM FCF for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM free cash flow is $2.08 M
What is Soleno Therapeutics TTM FCF year-on-year change?
Over the past year, SLNO TTM free cash flow has changed by $0.00 (0.00%)